The 2012 Network-wide Meeting was hosted at the Royal Sonesta Hotel in Cambridge, MA and the Museum of Science, Boston. The meeting featured a scientist roundtable, evening of public programs and exhibits at the Museum of Science, concurrent sessions, and opportunities for NISE Network partners to meet and share their own work with others in the Network.
Attendance at the Network-wide Meeting was invitation-only due to space and budgetary limitations.
Links to materials and downloadable presentations are available for most sessions for those unable to attend the meeting in person.
At the Royal Sonesta Hotel
7:30 - 9:00 am Registration
8:00 am Breakfast
9:00 am Welcome and what's new in the NISE Network
10:00 am Plenary: Nano 2012 and Beyond
Ponder next generation nanotechnologies in electronics, medicine, and biology with three leading innovators, then discuss how to share these nanotechnologies more broadly.
12:15 pm Lunch
2:00 pm Concurrent Sessions (See full session descriptions and presentations here)
Evening Event at the Museum of Science
4:00 pm Free time in the Museum of Science exhibit halls
4:45 pm NISE Net Stage Presentations in Cahners Theater
6:00 pm NISE Net Hands-On Activities and Cash Bar in the Blue Wing
6:30 pm Dinner in the Blue Wing, Lower Level
8:00 pm Evening performance of the Amazing Nano Brothers Juggling Show
At the Royal Sonesta Hotel
7:30 - 8:45 am Breakfast for all attendees, set-up for partner showcase
8:00 am Breakfast for Nano & Society Workshop attendees
1:30 pm Partner showcase/poster session
2:15 pm Themed discussion tables
5:00 pm Closing remarks
6:15 pm Dinner on your own
Location: ArtBar Restaurant, Royal Sonesta Hotel
7:30 - 9:00 am Website Team Meeting
At the Museum of Science
8:00 - 9:30 am RISE Team Meeting
9:00 - 11:00 am Community Team Meeting
9:00 am - noon Research Team Meeting
11:00 am - 4:00 pm Inclusive Audiences Team Meeting
noon - 4:00 pm Evaluation Team Meeting
Light and Power: Opportunities in Optoelectronics - Vladimir Bulović
Vladimir Bulović is a Professor of Electrical Engineering at MIT. He leads the Organic and Nanostructured Electronics laboratory, directs the Microsystems Technology Laboratories, and co-directs the MIT-ENI Solar Frontiers Center. Dr. Bulović’s research interests include studies of the physical properties of organic and organic/inorganic nanocrystal composite thin films and structures and the development of novel nanostructured optoelectronic devices. He is an author of more than 140 research articles with over 8000 citations, and holds more than 50 U.S. patents in technologies associated with light emitting diodes, lasers, photovoltaics, photodetectors, chemical sensors, programmable memories, and microelectromachines. The majority of these technologies have been licensed and utilized by start-up as well as established multinational companies. Dr. Bulović is a founder of the Massachusetts company QD Vision, Inc., which produces quantum dot optoelectronic components for applications such as lighting. He is also a founder of the California company Kateeva, Inc., which develops printed organic electronics, and a founder of Ubiquitous Energy, Inc., which develops nanostructured solar technologies. On a visit to MIT in 2009, President Obama dashed off his signature and the comment “Great work!” on a vacuum chamber in the Bulović lab. Dr. Bulović received his B.S.E and Ph.D. in electrical engineering from Princeton University.
Bringing Nanomedical Technologies from Bench to Bedside - Omid Farokhzad
Omid Farokhzad is an Associate Professor at Harvard Medical School (HMS) and a physician-scientist in the Department of Anesthesiology at Brigham and Women's Hospital (BWH). He directs the Laboratory of Nanomedicine and Biomaterials at BWH and is on the faculty of the Brigham Research Institute Cancer Research Center. He is also a member of Dana Farber/Harvard Cancer Center Programs in Prostate Cancer and Cancer Cell Biology. Dr. Farokhzad has extensive experience developing therapeutic nanoparticle technologies. He has authored more than 85 papers and is an inventor of more than 65 issued and pending patents. These technologies formed in part the foundation for the launch of three venture-backed biotechnology companies, BIND Biosciences, Selecta Biosciences, and Blend Therapeutics. Dr. Farokhzad was elected to the College of the Fellows of the American Institute for Medical and Biological Engineering. In 2012, he was named an Ernst & Young Entrepreneur of the Year for the Northeast Region. He has been awarded the Nano50 by the NASA Nanotech Briefs and the All Star Award by Mass High Tech for his contributions to life sciences. Dr. Farokhzad completed his post-doctoral clinical and research trainings, respectively, at the BWH/HMS and MIT in the laboratory of Dr. Robert Langer. He received his M.D. and M.A. from Boston University.
Organic Nanomanufacturing: Building with Biology - Pamela Silver
Pamela Silver is the Elliot T. and Onie H. Adams Professor of Biochemistry and Systems Biology at Harvard Medical School. She is one of the founding members of Harvard University’s Wyss Institute for Biologically Inspired Engineering, and a Fellow of the Radcliffe Institute. Her lab focuses on predictable design and re-programming of biological systems for applications in health and sustainability. Projects include designing novel genetic pathways to probe basic cell biology; engineering cell metabolism to produce medicines, commodity chemicals, and fuels; optimizing photosynthetic carbon fixation in cyanobacteria and plants; and developing novel electrofuel producing agents. Dr. Silver has more than 220 publications to her name and numerous patents. She’s received multiple awards and honors, including an NSF Presidential Young Investigator at Princeton University, a Mentoring Award for the PhD Program in Biological and Biomedical Sciences at Harvard Medical School, and a current NIH MERIT award. Her work was recognized with an Innovation Award at BIO2007 and has been funded by grants from the NIH, DOD, DOE, DATPA, NSF, Novartis, Merck and The Keck Foundation. Dr. Silver also serves on a variety of government and private advisory panels. She completed her post-doctoral work at Harvard, and received her B.S. in Chemistry and Ph.D. in Biochemistry from the University of California.